Ingevity (NGVT) Stock Price

Ingevity Price

NYSE·CLOSED
74.80USD+0.03 (+0.04 %)
Market closed

Over the last 13 years Ingevity grew revenue by 1.7% annually, reaching 1.17 B USD. Earnings per share have grown at 7.9% per year over the last 8 years. For Ingevity, the net margin of -14.3% is down versus 8.5% a few years ago. The consensus 12-month price target for Ingevity is 71.91 USD, about 3.9% below where the stock trades today. Of 10 analysts, 8 rate the stock a buy — an overall Buy consensus. The stock trades about 85% above its 52-week low.

Ingevity stock price

Volume
Details

Stock Price

How to Read This Chart

This chart tracks the historical stock price of Ingevity over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Ingevity stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Ingevity's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Ingevity Stock Price History
DateIngevity Price
7/21/202674.80 USD
7/20/202674.77 USD
7/17/202676.53 USD
7/16/202675.17 USD
7/15/202674.51 USD
7/14/202672.94 USD
7/13/202671.49 USD
7/10/202672.07 USD
7/9/202672.19 USD
7/8/202671.26 USD
7/7/202673.36 USD
7/6/202672.70 USD
7/2/202672.49 USD
7/1/202672.58 USD
6/30/202674.67 USD
6/29/202673.75 USD
6/26/202677.12 USD
6/25/202674.17 USD
6/24/202674.75 USD
6/23/202672.66 USD
6/22/202674.31 USD
6/18/202672.44 USD
6/17/202672.55 USD
6/16/202671.86 USD
6/15/202671.96 USD
6/12/202672.94 USD
6/11/202669.53 USD
6/10/202669.07 USD
6/9/202669.04 USD
6/8/202666.93 USD
6/5/202665.87 USD
6/4/202665.85 USD
6/3/202667.27 USD
6/2/202667.90 USD
6/1/202666.01 USD
5/29/202668.57 USD
5/28/202668.96 USD
5/27/202669.25 USD
5/26/202667.93 USD
5/22/202665.46 USD
5/21/202664.89 USD
5/20/202665.80 USD
5/19/202665.02 USD
5/18/202666.50 USD
5/15/202667.58 USD
5/14/202671.37 USD
5/13/202671.26 USD
5/12/202671.56 USD
5/11/202674.44 USD
5/8/202675.63 USD
5/7/202674.07 USD
5/6/202677.87 USD
5/5/202677.10 USD
5/4/202673.79 USD
5/1/202675.92 USD
4/30/202676.19 USD
4/29/202673.07 USD
4/28/202674.74 USD
4/27/202676.32 USD
4/24/202676.41 USD
4/23/202675.26 USD
4/22/202674.59 USD
4/21/202674.40 USD
4/20/202675.17 USD
4/17/202675.20 USD
4/16/202673.74 USD
4/15/202674.21 USD
4/14/202676.56 USD
4/13/202675.98 USD
4/10/202675.25 USD
4/9/202674.98 USD
4/8/202673.40 USD
4/7/202670.57 USD
4/6/202670.48 USD
4/2/202671.09 USD
4/1/202672.28 USD
3/31/202671.23 USD
3/30/202669.56 USD
3/27/202670.57 USD
3/26/202671.35 USD
3/25/202671.78 USD
3/24/202669.50 USD
3/23/202666.80 USD
3/20/202663.62 USD
3/19/202665.35 USD
3/18/202665.69 USD
3/17/202667.86 USD
3/16/202665.65 USD
3/13/202664.61 USD
3/12/202664.07 USD
3/11/202664.16 USD
3/10/202665.51 USD
3/9/202666.08 USD
3/6/202664.95 USD
3/5/202667.19 USD
3/4/202669.88 USD
3/3/202670.66 USD
3/2/202671.64 USD
2/27/202672.03 USD
2/26/202670.52 USD
2/25/202669.60 USD
2/24/202671.12 USD
2/23/202670.72 USD
2/20/202672.19 USD
2/19/202672.52 USD
2/18/202674.31 USD
2/17/202675.81 USD
2/13/202676.57 USD
2/12/202675.29 USD
2/11/202674.91 USD
2/10/202673.65 USD
2/9/202673.09 USD
2/6/202672.69 USD
2/5/202670.80 USD
2/4/202672.17 USD
2/3/202669.77 USD
2/2/202667.25 USD
1/30/202665.79 USD
1/29/202665.92 USD
1/28/202666.25 USD
1/27/202666.88 USD
1/26/202669.27 USD
1/23/202669.44 USD
1/22/202668.60 USD
1/21/202667.06 USD
1/20/202665.01 USD
1/16/202666.17 USD
1/15/202666.93 USD
1/14/202665.96 USD
1/13/202665.80 USD
1/12/202665.57 USD
1/9/202664.44 USD
1/8/202663.78 USD
1/7/202661.96 USD
1/6/202662.87 USD
1/5/202660.86 USD
1/2/202660.09 USD
12/31/202559.18 USD
12/30/202559.30 USD
12/29/202559.48 USD
12/26/202560.15 USD
12/24/202559.98 USD
12/23/202559.51 USD
12/22/202559.77 USD
12/19/202558.61 USD
12/18/202559.59 USD
12/17/202558.27 USD
12/16/202557.26 USD
12/15/202557.52 USD
12/12/202558.87 USD
12/11/202560.47 USD
12/10/202558.83 USD
12/9/202556.05 USD
12/8/202553.98 USD
12/5/202552.91 USD
12/4/202552.25 USD
12/3/202552.54 USD
12/2/202551.64 USD
12/1/202551.62 USD
11/28/202552.23 USD
11/26/202552.17 USD
11/25/202552.16 USD
11/24/202550.96 USD
11/21/202549.56 USD
11/20/202547.48 USD
11/19/202548.51 USD
11/18/202547.99 USD
11/17/202547.12 USD
11/14/202549.37 USD
11/13/202550.53 USD
11/12/202549.15 USD
11/11/202549.53 USD
11/10/202549.86 USD
11/7/202548.40 USD
11/6/202546.20 USD
11/5/202554.46 USD
11/4/202552.58 USD
11/3/202553.84 USD
10/31/202553.72 USD
10/30/202553.51 USD
10/29/202553.76 USD
10/28/202555.72 USD
10/27/202556.09 USD
10/24/202557.17 USD
10/23/202556.37 USD
10/22/202555.84 USD
10/21/202555.90 USD
10/20/202556.18 USD
10/17/202554.32 USD
10/16/202555.50 USD
10/15/202555.65 USD
10/14/202554.83 USD
10/13/202553.59 USD
10/10/202552.85 USD
10/9/202554.00 USD
10/8/202554.37 USD
10/7/202553.46 USD
10/6/202555.01 USD
10/3/202555.01 USD
10/2/202556.31 USD
10/1/202554.44 USD
9/30/202555.19 USD
9/29/202554.51 USD
9/26/202555.11 USD
9/25/202554.36 USD
9/24/202555.31 USD
9/23/202556.13 USD
9/22/202556.70 USD
9/19/202556.35 USD
9/18/202557.84 USD
9/17/202556.58 USD
9/16/202556.28 USD
9/15/202558.69 USD
9/12/202558.15 USD
9/11/202558.78 USD
9/10/202557.09 USD
9/9/202558.80 USD
9/8/202560.74 USD
9/5/202559.77 USD
9/4/202558.88 USD
9/3/202557.89 USD
9/2/202558.55 USD
8/29/202558.38 USD
8/28/202557.95 USD
8/27/202557.40 USD
8/26/202556.99 USD
8/25/202556.87 USD
8/22/202557.79 USD
8/21/202554.54 USD
8/20/202554.72 USD
8/19/202555.16 USD
8/18/202555.35 USD
8/15/202554.57 USD
8/14/202555.09 USD
8/13/202555.50 USD
8/12/202553.86 USD
8/11/202552.20 USD
8/8/202551.27 USD
8/7/202550.51 USD
8/6/202548.89 USD
8/5/202549.56 USD
8/4/202540.85 USD
8/1/202540.40 USD
7/31/202541.79 USD
7/30/202542.35 USD
7/29/202544.09 USD
7/28/202545.66 USD
7/25/202546.40 USD
Access this data via the Eulerpool API

Ingevity Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2020
1.22 B USD
297.60 M USD
181.40 M USD
Jan 1, 2021
1.39 B USD
307.20 M USD
118.10 M USD
Jan 1, 2022
1.67 B USD
341.00 M USD
211.60 M USD
Jan 1, 2023
1.69 B USD
256.40 M USD
-5.40 M USD
Jan 1, 2024
1.41 B USD
259.90 M USD
-430.30 M USD
Jan 1, 2025
1.17 B USD
261.90 M USD
-167.10 M USD
Jan 1, 2026 (e)
1.11 B USD
307.70 M USD
181.86 M USD
Jan 1, 2027 (e)
1.13 B USD
334.22 M USD
215.76 M USD

Ingevity Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jul 25, 2026, 7:45 AM
 
REVENUEB USD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM USD
EBITM USD
EBIT MARGIN%
NET INCOMEM USD
NET INCOME GROWTH%
SHARESM
201220132014201520162017201820192020202120222023202420252026e2027e
0.940.981.040.970.910.971.131.291.221.391.671.691.411.171.111.13
4.376.22-7.01-6.207.0516.5614.03-5.8814.3919.911.44-16.90-17.00-5.061.99
31.6330.1031.0329.0330.1833.8536.7237.3138.2436.8134.1727.8432.2939.5039.5039.50
297.00295.00323.00281.00274.00329.00416.00482.00465.00512.00570.00471.00454.00461.00437.69446.38
202.00192.00211.00167.00160.00202.00262.00327.00297.00307.00341.00256.00259.00261.00307.00334.00
21.5119.5920.2717.2517.6220.7823.1225.3124.4222.0720.4415.1318.4222.3727.7129.56
119.00119.00129.0080.0035.00126.00169.00183.00181.00118.00211.00-5.00-430.00-167.00181.00215.00
8.40-37.98-56.25260.0034.138.28-1.09-34.8178.81-102.378,500.00-61.16-208.3818.78
35.7035.7042.0742.0042.3042.6042.5042.2041.4039.6037.7036.2036.6035.7035.7035.70
Details

Income Statement Key Figures

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Ingevity generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Ingevity retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Ingevity's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Ingevity has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Ingevity's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Ingevity stock margins

The Ingevity margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Ingevity. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Ingevity.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2020
38.28 %
24.47 %
14.92 %
Jan 1, 2021
36.85 %
22.08 %
8.49 %
Jan 1, 2022
34.17 %
20.44 %
12.68 %
Jan 1, 2023
27.89 %
15.15 %
-0.32 %
Jan 1, 2024
32.33 %
18.48 %
-30.60 %
Jan 1, 2025
39.53 %
22.43 %
-14.31 %
Jan 1, 2026 (e)
39.53 %
27.75 %
16.40 %
Jan 1, 2027 (e)
39.53 %
29.56 %
19.08 %

Ingevity Stock Revenue, EBIT, Earnings per Share

The Ingevity earnings per share therefore indicates how much revenue Ingevity has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2020
29.37 USD
7.19 USD
4.38 USD
Jan 1, 2021
35.14 USD
7.76 USD
2.98 USD
Jan 1, 2022
44.25 USD
9.05 USD
5.61 USD
Jan 1, 2023
46.74 USD
7.08 USD
-0.15 USD
Jan 1, 2024
38.43 USD
7.10 USD
-11.76 USD
Jan 1, 2025
32.71 USD
7.34 USD
-4.68 USD
Jan 1, 2026 (e)
30.53 USD
8.62 USD
5.01 USD
Jan 1, 2027 (e)
31.13 USD
9.36 USD
5.94 USD

Ingevity business model & stock analysis

Ingevity Corp was founded in 1946 by Dr. Howard E. Baughman and is headquartered in North Charleston, South Carolina. The company is a global enterprise specializing in various types of machinery, vehicle, energy, and environmental technologies. The business model of Ingevity Corp is to develop products that help reduce environmental pollution and improve the performance of machines and vehicles. The company offers a wide range of solutions for various applications and works closely with customers from different industries to find individual solutions. Ingevity Corp operates in three business segments: Performance Chemicals, Performance Materials, and High Purity Fluids. The Performance Chemicals business segment offers a wide range of solutions for air and water filtration, fuel and oil processing, chemical intermediates, and construction chemicals. The air purification products of Ingevity Corp are used in many different industries, including automotive, aviation, construction, and food manufacturing. The Performance Materials business segment provides solutions for the production of polymers, composites, paints and coatings, as well as asphalt and concrete additives. Ingevity Corp's products improve the durability, strength, and surface quality of many materials used in various industries. The High Purity Fluids business segment produces high-purity liquids for electronic applications. These fluids are used in the semiconductor and electronics industry to avoid contamination and improve the performance of electronic devices. Some of the products manufactured by Ingevity Corp include activated carbon for reducing air and water pollution, resins and additives that improve the performance of fuels and oils, as well as fluids and chemicals for electronics and semiconductor manufacturing. Ingevity Corp has a long history of innovation and has been recognized for its achievements in the environmental and technology industry. In 2018, the company was honored by Fortune as one of the world's most admired companies. Overall, Ingevity Corp is a leading company in the environmental and technology industry that focuses on developing environmentally friendly solutions to improve the performance of machines and vehicles. With its three business segments and wide range of products, it is well positioned to meet the needs of its customers and continue to grow and innovate.

Ingevity SWOT Analysis

Strengths

Ingevity Corp benefits from the following strengths:

  • Strong product portfolio in specialty chemicals segment.
  • Robust research and development capabilities.
  • Well-established partnerships with key industry players.
  • Strong brand reputation and customer loyalty.

Weaknesses

Ingevity Corp faces the following weaknesses:

  • Dependency on a limited number of suppliers.
  • Relatively high production costs impacting profitability.
  • Market vulnerability to global economic fluctuations.
  • Limited geographical presence compared to competitors.

Opportunities

Ingevity Corp can explore the following opportunities:

  • Increasing demand for environmentally friendly chemicals.
  • Growth potential in emerging markets.
  • Expansion through strategic acquisitions or partnerships.
  • Development of innovative products for emerging industries.

Threats

Ingevity Corp should be wary of the following threats:

  • Intense competition from existing and new players.
  • Increasing regulations and compliance requirements.
  • Fluctuating raw material prices impacting profit margins.
  • Potential disruptions in supply chain and logistics.

Ingevity Segments

Ingevity Revenue by Segment (1/3)

  • 3 Years

  • 5 Years

  • Max

Industrial Specialties product line
Automotive Technologies product line
Road Technologies product line
Pavement Technologies product line
Industrial Specialties product line (1)
Engineered Polymers product line
Road Markings product line
Oilfield Technologies product line
Process Purification product line
Details
Date
Industrial Specialties product line
Automotive Technologies product line
Road Technologies product line
Pavement Technologies product line
Industrial Specialties product line (1)
Engineered Polymers product line
Road Markings product line
Oilfield Technologies product line
Process Purification product line
Jan 1, 2018
440.50 M USD
362.00 M USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
114.20 M USD
38.40 M USD
Jan 1, 2019
385.50 M USD
454.90 M USD
0.00 USD
111.40 M USD
0.00 USD
122.10 M USD
0.00 USD
183.30 M USD
35.70 M USD
Jan 1, 2020
316.00 M USD
477.70 M USD
0.00 USD
186.80 M USD
0.00 USD
127.70 M USD
0.00 USD
75.60 M USD
32.30 M USD
Jan 1, 2021
493.50 M USD
0.00 USD
0.00 USD
195.40 M USD
0.00 USD
185.80 M USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2022
633.80 M USD
0.00 USD
0.00 USD
241.30 M USD
0.00 USD
244.70 M USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2023
532.30 M USD
0.00 USD
369.80 M USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2024
0.00 USD
0.00 USD
342.30 M USD
0.00 USD
265.90 M USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2025
0.00 USD
0.00 USD
0.00 USD
302.60 M USD
0.00 USD
0.00 USD
97.90 M USD
0.00 USD
0.00 USD

Ingevity Revenue by Segment (2/3)

  • 3 Years

  • 5 Years

  • Max

Performance Chemicals
Performance Materials
Performance Chemicals segment
Advanced Polymer Technologies segment
Details
Date
Performance Chemicals
Performance Materials
Performance Chemicals segment
Advanced Polymer Technologies segment
Jan 1, 2018
733.20 M USD
400.40 M USD
0.00 USD
0.00 USD
Jan 1, 2019
802.30 M USD
490.60 M USD
0.00 USD
0.00 USD
Jan 1, 2020
706.10 M USD
510.00 M USD
0.00 USD
0.00 USD
Jan 1, 2021
0.00 USD
0.00 USD
874.70 M USD
0.00 USD
Jan 1, 2022
0.00 USD
0.00 USD
1.12 B USD
0.00 USD
Jan 1, 2023
0.00 USD
0.00 USD
902.10 M USD
204.00 M USD
Jan 1, 2024
0.00 USD
0.00 USD
608.20 M USD
188.60 M USD
Jan 1, 2025
0.00 USD
0.00 USD
400.50 M USD
160.20 M USD

Ingevity Revenue by Segment (3/3)

  • 3 Years

  • Max

Performance Materials
Details
Date
Performance Materials
Jan 1, 2018
0.00 USD
Jan 1, 2019
0.00 USD
Jan 1, 2020
0.00 USD
Jan 1, 2021
516.80 M USD
Jan 1, 2022
548.50 M USD
Jan 1, 2023
586.00 M USD
Jan 1, 2024
609.60 M USD
Jan 1, 2025
606.90 M USD

Ingevity Revenue by Region

  • 3 Years

  • 5 Years

  • Max

North America
United States
Asia Pacific
Europe, Middle East and Africa
Europe, Middle East, and Africa
China
South America
Details
Date
North America
United States
Asia Pacific
Europe, Middle East and Africa
Europe, Middle East, and Africa
China
South America
Jan 1, 2018
770.40 M USD
0.00 USD
171.40 M USD
169.90 M USD
0.00 USD
0.00 USD
21.90 M USD
Jan 1, 2019
795.70 M USD
0.00 USD
281.40 M USD
0.00 USD
193.60 M USD
0.00 USD
22.20 M USD
Jan 1, 2020
676.90 M USD
0.00 USD
345.40 M USD
0.00 USD
174.90 M USD
0.00 USD
18.90 M USD
Jan 1, 2021
763.30 M USD
0.00 USD
385.50 M USD
0.00 USD
219.60 M USD
0.00 USD
23.10 M USD
Jan 1, 2022
983.20 M USD
0.00 USD
398.70 M USD
0.00 USD
242.20 M USD
0.00 USD
44.20 M USD
Jan 1, 2023
1.07 B USD
0.00 USD
364.00 M USD
0.00 USD
215.50 M USD
0.00 USD
43.10 M USD
Jan 1, 2024
820.90 M USD
736.00 M USD
346.00 M USD
0.00 USD
187.00 M USD
184.30 M USD
52.50 M USD
Jan 1, 2025
665.10 M USD
585.00 M USD
298.50 M USD
0.00 USD
158.90 M USD
153.10 M USD
45.10 M USD

Ingevity Eulerpool Fair Value

Details

Fair Value Estimate

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Ingevity historical P/E ratio, EBIT multiple, and P/S ratio

Ingevity annual returns

Details

Annual Return

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Ingevity shares outstanding

The number of shares of Ingevity was 35.7 M in 2025. This indicates how many shares Ingevity is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2020
41.40 M Stocks
Jan 1, 2021
39.60 M Stocks
Jan 1, 2022
37.70 M Stocks
Jan 1, 2023
36.20 M Stocks
Jan 1, 2024
36.60 M Stocks
Jan 1, 2025
35.70 M Stocks
Jan 1, 2026 (e)
35.70 M Stocks
Jan 1, 2027 (e)
35.70 M Stocks

Current Ingevity forecasts and price targets in July 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy80.00 % (8)
Hold20.00 % (2)
Sell0.00 % (0)
12M Price Target
71.91
Last Price
73.76
Currency
USD
12M Return Potential
-2.51 %
LTM Return
0 %

Ingevity Earnings Estimates

DateEPS estimateRevenue EstimateQuarterly report
7/29/20261.35USD318.44 MUSD2026 Q2
5/6/20260.79USD259.83 MUSD2026 Q1
5/4/20260.79USD259.83 MUSD2026 Q1
2/25/20260.70USD262.41 MUSD2025 Q4
2/16/20260.70USD262.41 MUSD2025 Q4
5/1/20240.02USD328.03 MUSD2024 Q1
2/26/2024-0.12USD337.33 MUSD2023 Q4
7/31/20232.13USD470.89 MUSD2023 Q2
5/2/20231.61USD410.87 MUSD2023 Q1
2/21/20231.00USD402.31 MUSD2022 Q4

EESG©

Eulerpool ESG Scorecard© for the Ingevity stock

85/100
77
Environment
86
Social
91
Governance
E

Environment

20
Scope 1 - Direct Emissions241,299.9
Scope 2 - Indirect emissions from purchased energy139,613.4
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions380,913.3
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees24
Percentage of women in management
Percentage of Asian employees
Share of Asian management1.9
Percentage of Hispanic/Latino employees
Hispano/Latino Management share3.3
Percentage of Black employees
Black Management Share6.7
Percentage of white employees
White Management Share85.6
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Ingevity shareholder structure

% Name
14.42378%
BlackRock Institutional Trust Company, N.A.
BlackRock Institutional Trust Company, N.A.
11.25116%
The Vanguard Group, Inc.
The Vanguard Group, Inc.
6.00768%
Wellington Management Company, LLP
Wellington Management Company, LLP
4.70025%
American Century Investment Management, Inc.
American Century Investment Management, Inc.
4.12437%
State Street Investment Management (US)
State Street Investment Management (US)
3.53278%
Segall Bryant & Hamill, LLC
Segall Bryant & Hamill, LLC
...

Ingevity Executives and Management Board

MH

Ms. Mary Hall

(68)

Chief Financial Officer, Executive Vice President

Compensation2.06 M USD
LF

Mr. Luis Fernandez-Moreno

(63)

Director · since 2016

Compensation2.04 M USD
RW

Mr. Richard White

(62)

Senior Vice President, President - Performance Chemicals

Compensation1.44 M USD
RF

Mr. Ryan Fisher

(49)

Senior Vice President, General Counsel, Secretary

Compensation1.02 M USD
DS

Mr. Daniel Sansone

(72)

Independent Director

Compensation245,044.00 USD

Ingevity Supply Chain

Ingevity Supply Chain

Correlation: how closely stock prices move together

Same directionNo relationOpposite
14 companies
#Name1M3M6M1Y2YTrend
1
0.31
0.53
0.81
0.84
0.89
2
Solvay
Supplier
0.17
0.69
0.59
0.77
0.88
3
WestRock
Supplier
0.43
-0.13
-0.17
0.57
0.84
4
0.61
0.74
0.86
0.84
0.82
5
0.32
-0.44
-0.03
0.71
0.76
#Name1M3M6M1Y2YTrend
1
0.74
-0.44
-0.86
-0.83
0.23
2
0.76
-0.45
-0.84
-0.86
0.24

Frequently asked questions about Ingevity

The business model of Ingevity Corp revolves around supplying specialty chemicals and high-performance carbon materials. As a leading global provider, Ingevity focuses on addressing crucial environmental, energy, and purification challenges through innovative solutions. With a diverse portfolio, the company serves various sectors including automotive, construction, energy, and industrial markets. Ingevity Corporation leverages its advanced technologies and expertise to enhance the performance, efficiency, and sustainability of its customers' products. By consistently delivering exceptional value and sustainable solutions, Ingevity Corp has established itself as a trusted partner in the specialty chemicals industry.

All fundamentals and in-depth analysis of Ingevity

Our stock analysis for Ingevity stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Ingevity. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.